R&D-based industry federation EFPIA is unimpressed with the report the European Commission ordered as part of its efforts to tackle the serious problem of frequently occurring drug shortages across the EU. The trade body agrees that new policy action is required but questions whether the report provides sufficient clarity on this matter.
Noting the complexity of medicines supply chains, EFPIA said that while it supported the goal of improving the resilience of such chains and reducing the risk of shortages, "taking policy action to prevent or mitigate shortages requires prior
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?